Quarterly report pursuant to Section 13 or 15(d)

Common Shares and Warrants (Detail Narrative)

v3.24.1.u1
Common Shares and Warrants (Detail Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Oct. 03, 2023
Feb. 16, 2024
Oct. 26, 2023
Nov. 30, 2023
Nov. 30, 2022
Feb. 29, 2024
Feb. 28, 2023
Stock issued during period, shares           $ 1,119,250  
Proced from issuance of common stock           1,063,475  
Transferred to trust account           $ 32,110  
Term           3 years 7 months 17 days  
Stock based compensation       $ 53,953 $ 68,776 $ 53,953 $ 79,302
Unrecognized non-cash compensation costs           $ 39,117  
Non-vested stock options           11,750  
Option strike price           $ 3.27  
Weighted Average Remaining Contractual Life           26 days  
Exercise price           $ 0.95  
Officers And Employees [Member]              
Granted options     85,000        
Exercise price, option     $ 1.15        
Term     5 years        
Officers And Employees Additional [Member]              
Granted options     85,000        
Exercise price, option     $ 1.15        
Term     5 years        
Securities Purchase Agreement [Member]              
Proced from issuance of common stock $ 73         $ 1,063,475  
Purchase of common stock 889,272            
Purchase of Pre-funded warrants 729,058         113,702  
Common shares to be purchase 1,618,330 1,444,741       1,558,443  
Offering price $ 0.97         $ 2.31  
Exercise price $ 0.97         $ 2.185  
Net proceeds $ 1,250,000            
Equity Incentive Plan [Member]              
Description of incentives plan           The Company has established an Equity Incentive Plan which was most recently amended by the Company’s shareholders on May 9, 2023. Pursuant to the amendments which were effected on January 18, 2024 when the Company filed a Form S-8 Registration Statement, the Equity Incentive Plan now has an evergreen formula, whereby on January 1 each year commencing January 1, 2024, the number of shares issuable pursuant to the Equity Incentive Plan may be increased to a number equal to up to 10% of the issued share capital on December 31 of the previous year.  
Aggregate common shares issuable           1,037,544  
Additional shares to be issued           527,111  
Placement Agent [Member]              
Proced to direct offering           $ 3,000,000.0  
Common shares to be purchase           54,546  
Exercise price           $ 2.8875